Stay updated on Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:46:32.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the long-term safety study of ZX008 in subjects with Dravet syndrome, Lennox-Gastaut syndrome, or epileptic encephalopathy, reflecting potential advancements in medical research and healthcare documentation.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:58.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments. Additionally, the inclusion criteria now specify that participants must have successfully completed another Zogenix-sponsored clinical trial with ZX008.
    Difference
    10%
    Check dated 2024-05-22T21:21:09.000Z thumbnail image
  8. Check
    26 days ago
    Change Detected
    Summary
    The value 03 02 03 has recently changed to 17 16 17 on the webpage related to Medical and healthcare-related publications and documentation. This change likely signifies an update or modification in the data being presented.
    Difference
    0.4%
    Check dated 2024-05-21T15:53:24.000Z thumbnail image
  9. Check
    41 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change represents an update in the estimated primary completion date and study completion date for the clinical trial investigating the long-term safety of ZX008 in patients with rare seizure disorders such as Dravet syndrome and Lennox-Gastaut syndrome.
    Difference
    0.1%
    Check dated 2024-05-06T17:27:45.000Z thumbnail image
  10. Check
    43 days ago
    Change Detected
    Summary
    The value 04 19 04 18 04 19 04 has recently changed to 05 03 05 02 (Estimated) 05 03 05. This change likely represents an update in the estimated primary completion date and study record update date for a clinical trial related to ZX008 (Fenfluramine Hydrochloride) in patients with rare seizure disorders such as Dravet Syndrome and Lennox-Gastaut Syndrome.
    Difference
    0.9%
    Check dated 2024-05-04T09:43:50.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.